Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?

Bijan J. Borah, Naveen Pereira, Michael E. Farkouh

Research output: Contribution to journal › Editorial › peer-review

Fingerprint

Dive into the research topics of 'Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?'. Together they form a unique fingerprint.